In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
From 1999 to 2012 the percentage of Americans on antidepressants increased from 6.8% to 13%, according to a report published this week by the...
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.
The use of antidepressants has increased substantially in recent years, yet relatively few studies have asked patients about their experiences with these drugs. A...
Ayahuasca found to be effective in treating moderate to severe depression in low-income population.
Prominent researchers in psychiatry urge the field to move away from a rigid biological focus toward social and psychological perspectives to meet the needs of today’s world.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Jay Amsterdam, who first blew the whistle on corrupt research practices in a study conducted by GlaxoSmithKline (GSK) eight years ago, has now submitted...
A third of patients who have taken the common psychiatric medication lithium for over ten years have developed "chronic renal failure" from the drug.
Counseling clients in the UK who found CBT unhelpful were interviewed about their experiences.
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
Lithium appears to reduce libido and sexual function, and more research into the problem is needed.
Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.
MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.
While a great deal of the excitement about advances in psychological treatments comes from the potential for research in neuroscience to unlock the secrets of the brain, many mental health experts would like to temper this enthusiasm. A special issue of the Behavior Therapist released this month calls into question the predominant conception of mental illnesses as brain disorders.
: A new review finds evidence of spin and the misrepresentation of clinical trials with non-significant results.
Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.
An anthropological look at the Global Mental Health (GMH) movement suggests several ethical problems and contradictions in its mission.
A new article explores Mahi a Atua, an affirming indigenous Māori healing practice which stands in contrast to the Western psychiatric methods typically promoted by the Movement for Global Mental Health.
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...
Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...
A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.